Evidence map›Paper›PMID 41838727›Full record

ArticlePloS one2026

Can the current radiation dose, in chest tomosynthesis, be reduced with retained image quality? A study in the context of lung cancer screening programs.

Masoud Jadidi, Angelica Svalkvist, Magnus Båth, Sven Nyrén

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masoud JadidiDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0009-0001-8200-0842
Angelica SvalkvistDepartment of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.
Magnus BåthDepartment of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sven NyrénDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDigital chest tomosynthesis (DTS) is a low-cost and low- dose imaging technique that has not yet reached general use. It might, however, be well suited to lung cancer screening programs. In lung cancer screening, it is essential to keep radiation dose low, as a large number of healthy individuals have to be examined to detect one case of lung cancer. Lung cancer screening has been proven to lower deaths in lung cancer by approximately 20%, but this limited success comes at high cost. We believe that adding interval examination with DTS to lung cancer screening programs could increase survival and reduce cost, without significantly increasing the radiation dose to the individual. We therefore conducted this study to investigate if the current radiation dose, in chest tomosynthesis, could be reduced with retained image quality.

methods50 patients with known or suspected lung malignancy were imaged with chest X-ray equipment using the tomosynthesis option. Three DTS examination protocols were applied for each patient. One DTS examination was performed with the dose level as in the vendor-recommended protocol, and two other examinations were performed with low-dose protocols, reducing the exposure dose by 30% and 50%, respectively. Images from all three protocols were processed using the vendor-recommended post-processing settings, including a filtered back projection algorithm. The images generated by the DTS protocols were evaluated by four observers anonymously and in random order. The observers rated the quality of the reconstructed section images according to predefined quality criteria for different thoracic regions. Visual grading characteristics (VGC) were used to analyze the data, and the area under the VGC curve (AUCVGC) was used as a figure-of-merit.

resultsThe result of VGC analysis showed no reduction in imaging quality for the protocol with a 30% dose reduction compared with the vendor-recommended protocol for any of the classes of criteria, namely demarcation (AUCVGC = 0.51, p = 0.57), disturbance (AUCVGC = 0.51, p = 0.59) bone structure (AUCVGC = 0.50, p = 0.88), and tumor homogeneity (AUCVGC = 0.47, p = 0.09). For the protocol with a 50% dose reduction, image quality was reduced for the classes of criteria demarcation (AUCVGC = 0.47, p = 0.03) and disturbance (AUCVGC = 0.47, p = 0.02) compared with the vendor-recommended protocol, while no quality reduction was found for the classes of bone structure (AUCVGC = 0.50, p = 0.79) and tumor homogeneity (AUCVGC = 0.46, p = 0.10).

conclusionsThis study has not shown any reduction in image quality from reducing the radiation dose by 30%, compared with the vendor-recommended protocol, which might indicate that such a reduction could be used in clinical practice.

Indexed as

Early Detection of CancerLung NeoplasmsRadiation DosageRadiography, ThoracicTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedRadiographic Image Enhancement

Identifiers

PMID41838727
PMCPMC12991223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.